Inhibrx Biosciences Inc (INBX)
EBITDA
-$30.48M
Quarterly · Period ending: · USD
INBX EBITDA
Latest reported-$30.48Mperiod ending
Latest reported-$30.48Mperiod ending
INBX Quarterly EBITDA (-$7.76M → -$30.48M)
Quarterly EBITDA
High-resolution chart · PNG
INBX ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -30,477,000 | |
| -29,395,000 | |
| -29,085,000 | |
| -31,492,000 | |
| -24,850,000 | |
| -39,947,000 | |
| -47,176,000 | |
| -43,104,000 | |
| 1,863,850,000 | |
| -70,220,000 | |
| -87,991,000 | |
| -43,334,000 | |
| -38,848,000 | |
| -41,058,000 | |
| -35,198,000 | |
| -29,694,000 | |
| -34,273,000 | |
| -28,673,000 | |
| -19,097,000 | |
| -18,503,000 | |
| -19,498,000 | |
| -18,251,000 | |
| -16,849,000 | |
| -15,558,000 | |
| -16,923,000 | |
| -17,345,000 | |
| -16,517,000 | |
| -16,071,000 | |
| -4,366,000 | |
| -2,836,000 | |
| -3,883,000 | |
| -6,496,000 | |
| -8,718,000 | |
| -7,761,000 |